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SUMMARY 
Belibasakis GN, Emingil G, Saygan B, Turkoglu O, Atilla G, Bostanci N. Gene 
expression of transcription factor NFATc1 in periodontal diseases. 
 
Periodontitis is a disease of infectious aetiology that causes inflammatory destruction 
of the tooth-supporting tissues. Activated T-cells are central to the pathogenesis of the 
disease, by producing Receptor activator of NF-? B ligand (RANKL) that stimulates 
bone resorption. Antigenic activation of T-cells is regulated by the induction of 
transcription factor Nuclear Factor of Activated T cells, cytoplasmic 1 (NFATc1). 
There is as yet no information on the potential involvement of NFATc1 in periodontal 
diseases. This study aimed to investigate NFATc1 gene expression levels in 
periodontal diseases, and analyse the potential correlation with RANKL expression 
and clinical periodontal parameters. In this cross-sectional study, gingival tissue 
biopsies were obtained from healthy (n = 10) and periodontally diseased (n = 58) 
sites. NFATc1 and RANKL gene expression levels in these samples were analysed by 
quantitative real-time polymerase chain reaction. Compared to healthy subjects, 
patients with gingivitis, chronic and aggressive periodontitis, exhibited higher 
NFATc1 expression, which proved to be statistically significant in the periodontitis 
groups. NFATc1 and RANKL expression levels strongly correlated with each other, 
and with clinical periodontal parameters. The increased expression of NFATc1 in 
periodontitis denotes a role for this transcription factor in the pathogenesis of the 
disease. 
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INTRODUCTION 
Periodontitis is characterised by loss of connective tissue attachment and alveolar 
bone destruction, as a result of inflammation triggered by bacterial biofilms attached 
on the tooth surface. If the disease is left untreated, it may eventually lead to tooth 
loss as a result of destruction of the supportive bone. The pathogenesis of the disease 
largely accounts for a host immune response to the bacterial infection, which is 
dominated by the presence of T-cells (1, 2). When recruited into the infected area, T-
cells can induce bone resorption by producing Receptor Activator of NF-kB Ligand 
(RANKL), the key osteoclast differentiation cytokine belonging to the tumor necrosis 
factor ligand family.  By activating its cognate RANK receptor on monocytes, 
RANKL triggers their fusion and differentiation into osteoclasts, an event that can be 
blocked by its soluble decoy receptor osteoprotegerin (OPG) (3, 4). Activated T-cells 
appear to be the primary source of RANKL in diseased periodontal tissues (1, 2, 5, 6). 
The recognition of bacterial antigens by immuno-receptors on T-cells leads to 
the production of T-cell-specific cytokines. This event is predominantly mediated by 
the inducible expression of  transcription factor Nuclear Factor of Activated T cells, 
cytoplasmic 1 (NFATc1, also NFAT2) (7, 8). This transcription factor is expressed at 
low levels in resting T-cells, but is strongly induced upon activation, in order to 
enhance and sustain the expression of genes crucial for peripheral T-cell development 
and function (9). NFATc1 expression is also recently identified in differentiating 
osteoclasts and is considered to be the major intracellular regulator of 
osteoclastogenesis downstream of RANKL (10, 11). The dendritic cell–specific 
transmembrane protein (DC-STAMP) is also induced in osteoclasts upon RANKL 
stimulation and is involved in their fusion and multi-nucleation (12).  
As there is as yet no clinical evidence available on the involvement of 
NFATc1 and DC-STAMP in periodontal diseases, the present cross-sectional study 
aimed to investigate their gene expression levels in gingival tissue samples of healthy 
and periodontally diseased subjects. 
 
MATERIALS AND METHODS 
Study population and clinical examination 
A total of 58 subjects were included in this study, recruited from the Department of 
Periodontology, School of Dentistry, Ege University, I zmir (13). The use of human 
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subjects satisfied the requirements of Ege University Ethics Review Board, and was 
conducted in accordance to the Declaration of Helsinki. Written and informed consent 
was obtained from each subject prior to enrolment in the study. Patients were selected 
according to the clinical and radiographic criteria proposed by the 1999 International 
World Workshop for a Classification of Periodontal Disease and Conditions (14). 
Complete medical and dental histories were taken. None of the subjects had a history 
of systemic disease or cigarette smoking, and had not taken medications such as 
antibiotics or contraceptives that could affect their periodontal status for at least 3 
months prior to the study. Clinical periodontal examination included measurement of 
probing pocket depth (millimeters), clinical attachment level (millimeters) at six sites 
around each tooth with a manual William’s periodontal probe (Hu-Friedy, Chicago, 
IL), papilla bleeding index (15) and plaque index (16). The healthy group consisted of 
3 females and 7 males (16-36, mean age 24.2 ± 8.4 years) with no clinical signs of 
gingival inflammation or radiographic evidence of alveolar bone loss. The gingivitis 
group included 4 female and 6 male patients (22-48 years, mean age 34.2 ± 8.7 years), 
with varying degrees of gingival inflammation and no radiographic evidence of 
alveolar bone loss. The generalized chronic periodontitis group included 8 females 
and 10 males (35-61 years, mean age of 46.6 ± 6.2 years). The patients in this group 
had at least 16 teeth in their mouth, demonstrating generalized (>30% of sites) severe 
periodontal destruction (clinical attachment loss = 5mm), with bleeding on probing 
scores >50%. The clinical attachment levels were commensurate with the amount of 
plaque accumulation of the patients. The generalized aggressive periodontitis group 
consisted of 12 females and 8 males (21-38 years, mean age 28.3 ± 4.6 years). These 
patients demonstrated a generalized pattern of severe periodontal destruction and 
clinical attachment loss of =  4 mm on eight or more teeth, at least three of which were 
other than central incisors or first molars. They also showed severe periodontal tissue 
destruction and loss of periodontal support inconsistent with their age. 
 
Colection of gingival tissue samples 
After screening, the patients were recalled for sampling, prior to entering any therapy 
phase. A single gingival tissue biopsy was taken from each patient, from 
interproximal sites of single rooted teeth by gingivectomy, under local anesthesia. 
These biopsies included both gingival (junctional, crevicular or pocket) epithelium 
and gingival connective tissue. For the periodontitis groups, samples were collected 
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from sites with clinical attachment loss = 5 mm prior to non-surgical periodontal 
therapy. Gingival tissue samples from periodontally healthy and gingivitis-affected 
subjects were obtained during tooth extractions for orthodontic reasons or crown-
lengthening procedures. The selected sites had no clinical attachment loss or 
radiographic evidence of bone loss. One tissue sample from each subject was obtained 
and was immediately submerged in a sterile tube containing 1 ml RNAlater solution 
(Ambion Inc, Austin, TX) and stored at +4°C overnight, before long term storage at -
40°C until further laboratory analysis. 
 
RNA isolation and Reverse Transcription 
Total RNA from gingival tissue biopsies was extracted using the RiboPure RNA 
Isolation Kit (Ambion Inc, Austin, TX), and quantified using the NanoDrop® ND-
1000 spectophotometer. For the reverse transcription reaction, 1 µg of total RNA was 
incubated with 0.5 µg/ml of oligo dT primer at 70°C for 5 min and then cooled on ice. 
A master mix was then added to samples, comprising of 200 units moloney murine 
leukemia virus (M-MLV) reverse transcriptase and buffer, and 10 mM PCR 
Nucleotide Mix (all from Promega).  To obtain the single-stranded cDNA, these 
samples were then incubated at 40°C for 60 min, 70°C for 15 min, cooled down to 
+4°C for 5 min, and stored at -20°C until further use. 
 
TaqMan® quantitative real-time PCR (qPCR) 
The expression levels of RANKL, NFATc1 and DC-STAMP were investigated by 
qPCR analysis (ABI Prism 7000 Sequence Detection System, Applied Biosystems). 
The 18S rRNA was used as an endogenous RNA control in the samples. The standard 
PCR conditions for template amplification were 10 min at 95ºC, followed 40 cycles at 
95ºC for 15 seconds and 60ºC for 1 min. The TaqMan® Gene Expression Assay IDs 
(Applied Biosystems) were RANKL: Hs00243522-m1, NFATc1: Hs00542675-m1, 
DC-STAMP: Hs00229255-m1, and 18S rRNA: Hs99999901-s1. The qPCR assay was 
performed once and each sample was represented in triplicate wells. The relative 
expression levels of RANKL, NFATc1 and DC-STAMP were calculated by using the 
comparative Ct method (2- ? ? Ct formula) (17) after normalization to the 18S rRNA. 
This internal control has been efficiently used in the study of gene expression in 
gingival tissue biopsies (6). 
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Statistical analysis 
Statistical analyses were performed using non-parametrical methods. Comparisons 
between all groups were performed using the Kruskal–Wallis test. When there were 
significant differences (p<0.05), comparisons between groups were assessed with 
Dunn’s multiple comparison test. Correlations between RANKL and NFATc1 
expression levels, or clinical parameters, were analysed by Spearman's rank 
correlation. All data analyses were performed using the GraphPad Prism Software 4.0. 
 
RESULTS 
Clinical findings of sampling sites 
The clinical parameters of the sampled sites are provided in Table 1. The chronic and 
generalized aggressive periodontitis groups had significantly higher mean probing 
pocket depth and clinical attachment loss scores than the healthy and gingivitis groups 
(p<0.05). No significant differences were detected between gingivitis and 
periodontitis groups regarding the papilla bleeding index and plaque index of 
sampling sites (p>0.05). 
 
RANKL and NFATc1 and DC-STAMP gene expression analysis by qPCR 
The levels of RANKL, NFATc1 and DC-STAMP gene expression in gingival tissues 
were evaluated by qPCR analysis. RANKL expression was detected in 4/10 healthy, 
8/10 gingivitis, and all chronic periodontitis (18/18) and generalized aggressive 
periodontitis (20/20) tissue samples (Fig. 1). NFATc1 expression was detected in 8/10 
healthy, 9/10 gingivitis, and all chronic periodontitis (18/18) and generalized 
aggressive periodontitis (20/20) tissue samples (Fig. 2). On the contrary, DC-STAMP 
expression was sparsely detected (0/0 health, 2/10 gingivitis, 2/18 chronic 
periodontitis, and 3/20 generalized aggressive periodontitis) among the tissue samples 
(Fig. 3). Although numerically the relative DC-STAMP expression levels were higher 
in chronic and generalized aggressive periodontitis (1.13x105 and 0.66x105, 
respectively) compared to gingivitis (0.13x105), the low detection frequency 
prohibited further statistical analyses. 
In comparison to healthy tissues, both RANKL and NFATc1 expressions were 
higher in all three periodontal diseases groups. However, this difference proved to be 
significant in the cases of chronic and generalized aggressive periodontitis, but not in 
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gingivitis. In particular, RANKL expression was higher by 35.6-fold in generalized 
aggressive periodontitis, 15.8-fold in chronic periodontitis, and 9.3-fold in gingivitis, 
respectively (Fig. 1). In the case of NFATc1 expression, this was higher by 8.2-fold in 
generalized aggressive periodontitis, 6.0-fold in chronic periodontitis, and 3.7-fold in 
gingivitis, respectively (Fig. 2). When the two periodontitis groups were compared, 
no statistically significant differences were found in RANKL or NFATc1 expression. 
The Spearman’s rank correlation analysis was then used to investigate the 
association between RANKL and NFATc1 expression levels in all groups (Fig. 4). A 
strong positive correlation between the expression of these genes was revealed 
(r=0.846, p<0.0001). 
 
Correlation of RANKL and NFATc1 gene expression with clinical parameters 
Further analyses were performed in order to test whether there was an association of 
RANKL and NFATc1 expression levels with site-specific clinical parameters. For this 
purpose the Spearman's rank correlation analysis was used. The results indicated that 
the expression levels of both RANKL and NFATc1 were positively correlated 
(p<0.01) with probing pocket depth, clinical attachment levels, papilla bleeding index 
and plaque index (Table 2). 
 
DISCUSSION 
The present study demonstrated that NFATc1 gene expression in gingival tissues is 
elevated by the severity of periodontal disease, with a significant enhancement in 
chronic and generalized aggressive periodontitis, compared to health. This could be of 
potential importance for the pathogenic mechanisms of periodontal disease, as 
antigenic stimulation of NFATc1 is known to activate the functions of T-cells (8, 9). 
Hence, increased NFATc1 expression may confirm the increased T-cell activity in 
periodontitis. However, since NFATc1 is also involved in osteoclastogenesis, the 
findings could as well denote the presence of differentiating osteoclasts in 
periodontitis. Despite that the cell source of NFATc1 is not yet clear, this study 
indicates that NFATc1 up-regulation is an important molecular event in the 
pathogenesis of periodontitis. The present findings are also in agreement with a recent 
study demonstrating high NFATc1 expression in experimental periapical bone lesions 
(18).  
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RANKL gene expression was also investigated, confirming the general 
principle that it is elevated in periodontitis, thus strengthening further its role in the  
pathogenesis of the disease (5, 6, 19, 20). A strong positive correlation was also 
revealed between the gene expression levels of RANKL and NFATc1, indicating that 
they are concurrently expressed in periodontal tissues. Activated T-cells are 
considered the predominant cell type (21) and the major source of RANKL in 
periodontitis (1, 2, 5, 6). Hence, the findings support the likelihood that NFATc1 gene 
expression is associated with T-cells, rather than differentiating osteoclasts in the 
studied gingival tissue samples. This is further corroborated by the very limited 
detection of DC-STAMP in these samples, a molecule that is associated with the 
fusion and multi-nucleation of differentiating osteoclasts (12).  
Additional analyses were performed to evaluate the correlations of NFATc1 
and RANKL gene expression with clinical periodontal parameters. The results 
indicate that both NFATc1 and RANKL positively correlate with probing pocket 
depth, clinical attachment loss, papilla bleeding index and plaque index. These results 
confirm previous findings on RANKL expression (6), and further indicate that 
NFATc1 as well correlates with clinical parameters of periodontal disease severity.  
In conclusion, the present study provides the first evidence for the 
involvement of NFATc1 in periodontal disease. The increased expression of NFATc1 
in periodontitis justifies a further role for this transcription factor in the pathogenesis 
of the disease. To strengthen further the biological significance of the enhanced 
NFATc1 gene expression, further studies would be needed, confirming its protein 
localisation, as well as identifying its cellular source. 
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TABLES 
 
Table 1. Clinical parameters of the sampled sites (mean ± standard deviation) 
 PPD (mm) CAL (mm) PBI PI 
Healthy 1.7 ± 0.63 0 0.3 ± 0.4 0.8 ± 0.9 
Gingivitis 2.7 ± 0.6 0 2.6 ± 0.8* 2.2 ± 1.3 
CP 6.6 ± 0.8* 7.8 ± 1.7* 3.1 ± 1.7* 2.3 ± 0.7 
G-AgP 7.0 ± 1.2* 7.4 ± 1.6* 2.7 ± 1.4* 2.3 ± 0.8 
* Significant difference compared to healthy group (p < 0.05). PPD, probing pocket 
depth; CAL, clinical attachment levels; PBI, papilla bleeding index; PI, plaque index; 
CP, chronic periodontitis; G-AgP, generalized aggressive periodontitis. 
 
Table 2. Correlation values (r) between NFATc1 and RANKL gene expression levels 
and site-specific clinical parameters. 
Clinical Parameters NFATc1 RANKL 
PPD (mm) 0.374* 0.458* 
CAL (mm) 0.422* 0.530* 
PI 0.388* 0.413* 
PBI 0.479* 0.420* 
Spearman's rank correlation analysis was used. A positive correlation was revealed 
between RANKL or NFATc1 expression levels and all studied clinical parameters 
(*p<0.01). PPD, probing pocket depth; CAL, clinical attachment levels; PI, plaque 
index; PBI, papilla bleeding index. 
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FIGURE LEGENDS 
 
Figure 1 
Distribution of RANKL gene expression in gingival tissues of healthy subjects (n = 
10) and patients with gingivitis (n = 10), chronic periodontitis (n = 18) and 
generalized aggressive periodontitis (n = 20). The individual values represent the 
relative gene expression levels of RANKL, measured by qPCR analysis, and 
normalized against the expression levels of 18S rRNA. The horizontal line represents 
the mean value in each group. Statistically significantly differences compared to the 
healthy subject group (*p < 0.05). 
 
Figure 2 
Distribution of NFATc1 gene expression in gingival tissues of healthy subjects (n = 
10) and patients with gingivitis (n = 10), chronic periodontitis (n = 18) and 
generalized aggressive periodontitis (n = 20). The individual values represent the 
relative mRNA expression levels of NFATc1, measured by qPCR analysis, and 
normalized against the expression levels of 18S rRNA. The horizontal line represents 
the mean value in each group. Statistically significantly differences compared to the 
healthy subject group (*p < 0.05). 
 
Figure 3 
Distribution of DC-STAMP gene expression in gingival tissues of healthy subjects (n 
= 10) and patients with gingivitis (n = 10), chronic periodontitis (n = 18) and 
generalized aggressive periodontitis (n = 20). The individual values represent the 
relative mRNA expression levels of DC-STAMP, measured by qPCR analysis, and 
normalized against the expression levels of 18S rRNA. The horizontal line represents 
the mean value in each group. 
 
Figure 4 
Scatter plot demonstrating a strong positive correlation between RANKL and 
NFATc1 gene expression in gingival tissues (r = 0.846, p < 0.0001). 
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